Casey Ross is an investigative reporter for STAT News, where he covers AI development in healthcare and medicine. Last year he analyzed over 160 AI product market approval submissions cleared by the FDA between 2012 and 2020. As it turns out criteria for assessment and the dataset submitted differed a lot. Only 7 of 161 AI products cleared by the FDA in recent years, included any information about the racial composition of their datasets. Those devices were cleared to use AI for the diagnosis of a wide array of serious conditions, including heart disease, strokes, and respiratory illnesses.
In this discussion, Casey talks about the state of trust in AI solutions in healthcare, what have we learned from the development of IBM Watson, and more.
Enjoy the discussion, which you can also listen to wherever you get your podcasts. And if you’d like to see other topics and episodes as well, do go to www.facesofdigitalhealth.com.